Real-World Outcomes of Lenvatinib in Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Multicentre Retrospective Study.
- DOI
- 10.3390/cancers18172881
- Published
- 2026 Sep 6
- Container
- Cancers
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/cancers18172881,
title = {Real-World Outcomes of Lenvatinib in Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Multicentre Retrospective Study.},
author = {Chan WL and Tin WW and Wong KC and Kwok CC and Chow JCH and Liu TC and Cheung GT and Choi WY and Au LJ and To JC and Lo GY and Hou LY and Yeung KK and Leung HL and Kwong DL},
year = {2026},
journal = {Cancers},
doi = {10.3390/cancers18172881},
url = {https://doi.org/10.3390/cancers18172881}
}RIS
TY - JOUR TI - Real-World Outcomes of Lenvatinib in Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Multicentre Retrospective Study. AU - Chan WL AU - Tin WW AU - Wong KC AU - Kwok CC AU - Chow JCH AU - Liu TC AU - Cheung GT AU - Choi WY AU - Au LJ AU - To JC AU - Lo GY AU - Hou LY AU - Yeung KK AU - Leung HL AU - Kwong DL PY - 2026 JO - Cancers DO - 10.3390/cancers18172881 UR - https://doi.org/10.3390/cancers18172881 ER -
APA
WL, C., WW, T., KC, W., CC, K., JCH, C., TC, L., GT, C., WY, C., LJ, A., JC, T., GY, L., LY, H., KK, Y., HL, L., & DL, K. (2026). Real-World Outcomes of Lenvatinib in Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Multicentre Retrospective Study.. Cancers. https://doi.org/10.3390/cancers18172881
Source records
- pubmed · retrieved 2026-09-26T02:20:59.759Z